SCHEMBL16229083

SCHEMBL16229083

C=C(OCC)c1c[nH]c2cccc(C(F)(F)F)c2c1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.51
▸ CTNNB1 P35222 1/20 0.39
▸ WNT3A P56704 1/20 0.39
▸ CLEC4M Q9H2X3 1/20 0.38
▸ GABRA1 P14867 3/20 0.36
▸ GABRB2 P47870 3/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ GABRB1 P18505 2/20 0.36
▸ GABRA3 P34903 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NR4A2 P43354 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1350659 0.87 KDM4E (0.67) KDM4ECTNNB1WNT3ACLEC4MGABRA1
SCHEMBL12606659 0.81 CTNNB1 (0.42) KDM4ECTNNB1WNT3AMEN1ALDH1A1
SCHEMBL12606657 0.79 KDM4E (0.47) KDM4ECLEC4MJAK2JAK3NR4A2
SCHEMBL12606661 0.78 PBRM1 (0.46) KDM4ECTNNB1WNT3AMEN1ALDH1A1
SCHEMBL1353154 0.77 CYP1A2 (0.51) KDM4ECTNNB1WNT3AMEN1ALDH1A1
SCHEMBL29464955 0.76 ALDH1A1 (0.46) KDM4ECTNNB1WNT3AMEN1ALDH1A1
SCHEMBL27847428 0.75 GPR84 (0.40) KDM4ECTNNB1WNT3AJAK2JAK3
SCHEMBL2285923 0.73 CLEC4M (0.55) KDM4ECLEC4MGABRA1GABRB2JAK2
SCHEMBL11793589 0.72 CTNNB1 (0.49) KDM4ECTNNB1WNT3AMEN1ALDH1A1
SCHEMBL12134085 0.70 CFTR (0.52) KDM4EALDH1A1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884018-B2 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-11-11 — — US disclosed
Send feedback